Lamb Weston jumps 7.5% after earnings beat and guidance raise

What happened

Lamb Weston (LW) rose 7.5% on October 6, 2026, after fiscal Q1 2027 results beat estimates and the company raised its fiscal 2027 outlook. The stock closed at $47.91 after opening 5.5% above the previous close and trading at 4.2 times its 20-day average volume. Management cited stronger North America volume, cost-savings initiatives and improving pricing trends that offset international weakness, helping adjusted diluted EPS come in at $0.75 against a $0.59 consensus, 27.8% above estimates.

How big was the move

The day’s gain was 3.3 times a typical daily move for this stock and outpaced the Consumer Defensive sector by 7.0 percentage points on a day when the sector rose 0.5%. The S&P 500 rose 0.6% that session and rose 1.9% over the last five sessions; Lamb Weston rose 10.7% over the last five sessions. Trading volume at 4.2 times its 20-day average signaled outsized investor attention.

Because earnings were released at this session, the results were the direct cause of the move. The company reported net sales of $1.67 billion for the quarter, adjusted EBITDA of $285.6 million and net income of $29.1 million, and subsequently raised its fiscal 2027 outlook for net sales, adjusted diluted EPS and adjusted EBITDA.

Over the past five years the stock had 6 sessions with a gain of at least 7.5%; twenty trading days later the median result was a decline of 3.5%, and 1 of 6 were higher. The stock’s market sensitivity, with a beta of 0.37, indicates it tends to move less than the market, which made the size of the move notable for this company.

The technical picture

The stock was 5.1% above its 20-day moving average and 4.8% above its 200-day moving average, while it was 4.3% below its 50-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend. The Relative Strength Index (14 days) stood at 55, in a neutral range between 30 and 70.

The shares remained 28.6% below the 52-week high, and over one year the stock fell 23.8%, trailing the S&P 500 by 40.3 percentage points. Volatility was elevated: the stock’s 60-day annualized volatility was 36%, higher than 60% of its own readings over five years. Over shorter horizons, the stock fell 3.9% in the past month but rose 3.9% over three months, underscoring mixed momentum.

Fundamentals and valuation

For the four quarters through August 30, 2026, the company reported revenue of $6.62 billion, which grew 2.6% from a year earlier and slightly accelerated versus growth of 2.5% one quarter earlier. Diluted earnings per share were $1.83, which fell 12.4% from a year earlier. Gross margin was 19.4% versus 21.5% a year earlier, and operating margin was 7.8% versus 9.4% a year earlier.

Return on invested capital was 6.5%, and the balance sheet showed net debt of 4.6 times EBITDA. Share count over one year decreased by 1.2%. The stock traded at 26.2 times trailing earnings and 15.9 times expected forward earnings. Its price-to-earnings reading was higher than 62% of its own readings over the past five years, where the five-year median is 23.8 times earnings.

PromtFinance scores ranked the company weak on Value (42) and Quality (22), neutral on Growth (47), Momentum (55) and Revisions (54), and weak on Stability (32). Those readings point to a company with modest growth and margin pressure but with some price momentum following the quarter and guidance update.

Earnings and analyst expectations

Lamb Weston reported adjusted diluted EPS of $0.75 on October 6, 2026, against a $0.59 consensus, a 27.8% surprise. The company has recorded seven consecutive quarters beating estimates, with an average surprise over the last four reports of 22.2% above estimates. Typical two-day reactions after recent reports saw the stock fell 2.0%, but this session’s reaction was a rise because of the quarter and the following guidance raise.

Analysts’ consensus rating was Hold, based on 19 analysts, with 32% assigning a Buy. The consensus price target was $53.14, 10.9% above the closing price on October 6, 2026. Investors will weigh the upside implied by the consensus target against the company’s lower margins and elevated leverage.

What to watch

• Next report: December 18, 2026.
• Updated fiscal 2027 adjusted diluted EPS guidance: range of 3.050 to 3.350.
• Consensus price target: $53.14, 10.9% above the closing price.
• Net debt of 4.6 times EBITDA on the balance sheet.
• One-year change in share count: decreased by 1.2%.